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BACKGROUND 
Many drugs, both illicit or for medication, are known to influence driving abilities and increase 
risks of accidents (Figure 1).1-3 In Switzerland, national statistics for driving under the influence 
(DUI) of drugs are drawn from condemned offenses identified by the justice.4 However, little is 
known on abilities of police controls to identify use of cannabis, cocaine or other illicit drugs, 
and no data is available for drivers under prescribed medicinal drugs as this is not a legal 
offense.  
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OBJECTIVES 
The main goal of this cross-sectional study is to measure the prevalence of drivers under the 
influence of drugs in Western Switzerland using a representative sample and explore the 
association of drug use with age, gender, weekdays and time of the day. Secondarily, this 
study explores the ability of police roadside controls to detect DUI offense, and assesses the 
validity of self-reported drug consumption.  
METHODS 
Saliva samples from 1034 drivers were collected at different times of the day, at 24 different 
locations (Figure 2) in Western Switzerland for complete toxicological analysis.  
Twenty-seven police controls were organised for the study between October 2006 to April 
2008. Police officers selected a representative sample of drivers using a consecutive sampling 
method considered equivalent to a random sample. Usual roadside controls procedures, 
including BAC investigation, were applied before drivers were invited by an independent 
medical team to participate anonymously to a survey. Oral consent for participation was 
collected. Consent for taking a sample of saliva was however only sought after the 
questionnaire was completed to limit selection bias. Drivers arrested for DUI were not 
questioned but results from their toxicological investigations were made available. 
Blood and saliva were analysed for ethanol by HS-GC-FID (Agilent, USA). Blood alcohol 
concentrations (BAC) were measured in g/kg. Urine and blood were screened by 
immunoassays (EMIT, Siemens Healthcare Diagnostics, USA and ELISA, Mahsan, Germany) and 
GC-MS (Agilent, USA) for drugs. Drug concentrations in blood or urine were determined by 
GC-MS or LC-MS/MS (AB Sciex, Canada). Saliva was screened for drugs by LC-MS/MS using 
SmileMS (GeneBio, Switzerland).  
Illicit drugs for driving was defined by the Swiss legislation.5 Medicinal drugs affecting driving 
performance were defined using ICADTS categorisation system.6 The study was approved by 
the official state ethical committee. 
 
CONCLUSIONS  
Like in other developed countries, driving under the influence of psychoactive substances is 
common in Switzerland.7 Cocaine is the most frequent illicit drug detected in drivers but 
remains largely undetected by usual police roadside controls. Given the number of drivers 
under medicinal drugs, there is a need to legislate and define acceptable risks for driving 
under the influence of medicinal drugs. Further studies are required to develop rapid, reliable 
and cheap roadside screening methods for cocaine and benzodiazepines.  
Table 1:  Odds ratio of DUI depending of gender, age, time of the day and weekdays 
* Significant test is given by the likelihood ratio test for each factor within the model. 
† Gender was not reported on questionnaires for 36 drivers (n=999), and age for four drivers (n=1,031), and time of 
control for two drivers (n=1,033). 
 
 DUI OR  OR adj  
 n% with vs, n% without (CI95%)  (CI95%) p-value* 
      
Alcohol (= 0.02%)      
Gender (male)† 42 (6.0%) vs. 9 (3.0%) 2.1 (1.0 to 4.4)  2.1 (1.0 to 4.4) p = 0.050 
<35 yrs of age† 18 (4.7%) vs. 34 (5.3%) 0.89 (0.49 to 1.6)  0.75 (0.41 to 1.4) p = 0.337 
Night† 41 (7.4%) vs. 11 (2.3%) 3.4 (1.7 to 6.6)  3.8 (1.9 to 7.8) p = <0.001 
Weekends 15 (4.8%) vs. 37 (5.1%) 0.94 (0.51 to 1.7)  1.1 (0.6 to 2.1) p = 0.689 
Illicit drugs      
Gender (male) † 35 (5.0%) vs. 7 (2.3%) 2.2 (0.98 to 5.1)  2.3 (1.0 to 5.3) p = 0.046 
<35 yrs of age† 26 (6.8%) vs. 16 (2.5%) 2.9 (1.5 to 5.4)  2.6 (1.3 to 4.9) p = 0.004 
Night† 29 (5.2%) vs. 13 (2.7%) 2.0 (1.0 to 3.8)  1.8 (0.9 to 3.5) p = 0.104 
Weekends 17 (5.5%) vs. 25 (3.5%) 1.6 (0.86 to 3.0)    
Medicinal drugs      
Gender (male) † 52 (7.5%) vs. 20 (6.6%) 1.1 (0.67 to 1.9)  1.1 (0.64 to 1.9) p = 0.699 
<35 yrs of age† 15 (3.9%) vs. 60 (9.3%) 0.40 (0.22 to 0.71)  0.40 (0.22 to 0.74) p = 0.003 
Night† 35 (6.3%) vs. 41 (8.6%) 0.71 (0.45 to 1.1)  0.80 (0.49 to 1.3) p = 0.368 
Weekends 22 (7.1%) vs. 54 (7.5%) 0.94 (0.56 to 1.6)  1.0 (0.58 to 1.7) p = 0.994 
 
Table 2:  Sensitivity and specificity of self-reported consumption and police control for 
detecting DUI 
* n = 1,009 instead of 1,034 as questionnaires were not available from those having been arrested by the police and 10 questionnaires are missing. 
† For illicit drugs, life-time consumption was used as no driver reported having taken illicit drugs within the previous 12h; for medication we used reported 
administration within the previous 24h, for alcohol, we used consumption of any dose within the previous 4h. 
‡ Temporary results. Not all the results from screening have yet been analyzed by hand to detect cannabis from saliva. 
** For Self-reported consumption, data was only available for those with BAC values under 0.08% g/kg as the 14 drivers who were above were arrested and 
did not answer the questionnaire.  
†† Sensitivity and specificity were measured for detecting BAC of 0.8 g/kg or more. 
 Self-reported consumption*  Police control 
 Prevalence of 
positive answers 
n (%) 
Sensitivity 
% (CI95%) 
Specificity 
% (CI95%) 
 Prevalence 
of tests 
n (%) 
Sensitivity** 
% (CI95%) 
Specificity** 
% (CI95%) 
Illicit drugs† 49 (4.9%) 27.8 (14.8 to 45.4) 96.0 (94.5 to 97.1) 
 
6 (0.6%) 11.9 (4.5 to 26.4) 99.9 (99.3 to 100) 
Cannabis‡ 47 (4.7%) 100‡ (46.3 to 100) 95.8 (94.3 to 96.9)  6 (0.6%) 50.0 (20.1 to 79.9)‡ 100 (99.4 to 100) 
Cocaine   3 (0.3%) 6.7 (11.6 to 23.5) 99.9 (99.3 to 100)  6 (0.60%) 0.0 (0 to 13.7) 99.4 (98.6 to 99.8) 
Other   0 (0%) 0.0 (0 to 0.7) 95.1 (93.6 to 96.3)  6 (0.60%) 33.3 (1.8 to 87.5) 99.5 (98.8 to 99.8) 
Medicinal drugs 420 (40.6%) 63.2 (51.3 to 73.7) 61.2 (58.0 to 64.3)  6 (0.6%) 0.0 (0 to 6.0) 99.4 (98.6 to 99.7) 
Alcohol** 501 (49.7%) 31.4 (17.4 to 49.4)  49.6 (46.4 to 52.8)  1034 (100%) 100†† (73.2 to 100) 0†† (0 to 0.4%) 
 
Figure 4:  Prevalence with CI95% of drivers under the influence of drugs 
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RESULTS 
Toxicological findings were available for 1,034 (Figure 3). In Western Switzerland, DUI offense 
was observed for 5.3% (CI95% 4.0 to 6.9%) of drivers. Details of substances detected are given 
in Figure 3. Cocaine was the most common offense (3.0%), followed by excessive alcohol 
consumption (1.4%) and cannabis (1.0%).  
Medicinal drugs affecting driving performance were present in 77/1,034 drivers (7.4%; CI95% 
5.8 to 9.1). Benzodiazepines (BZP) were taken by 2.8% of drivers. Prevalence of other 
medicinal drugs are given in Figure 4. Twenty drivers (1.9%) were under the influence of at 
least two different medicinal types of drug, whereas ethanol and medicinal drugs were 
detected in 5 drivers (0.5%). 
Young, male drivers were more likely to drive under the influence of illicit drugs whereas older 
drivers were more likely to be under medicinal drugs (Table 1). 
Police control identified 19 of the 55 drivers who committed a DUI offense (34.5%). Breath 
analyser was efficient in detecting DUI offenders for alcohol when systematically used; blood 
samples confirmed all positive findings (14/14).  For illicit drugs, police detected one driver 
out of two under the influence of cannabis, but none of the 31 drivers under cocaine. Both 
police interceptions and self-reported consumption were shown to be a poor indicators of 
drug use for roadside studies (Table 2).   
Figure 1:  Increased risks (CI95%) of road casualties under the 
influence of drugs (literature review) 
Figure 3:  Drivers screened for drugs Figure 2:  Highway above Montreux 
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